Bexsero Injection, Suspension
Product Images NDC 58160-976

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexsero (NDC 58160-976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bexsero 10 Count Syringe Carton (Bexsero Spl Graphic 01)

Packaging label for Bexsero Meningococcal Group B Vaccine, indicated for use from 10 through 25 years of age. The label shows 10 single-dose prefilled syringes of 0.5 mL each, without included needles. Labeler is GlaxoSmithKline Biologicals SA. The label features the product name, dosing information, and the GSK logo.*

FDA Label Image

Bexsero Syringe Label (Bexsero Spl Graphic 02)

The label for Bexsero meningococcal group B vaccine injection, suspension includes the product name "Bexsero" and dosage form of 1 dose (0.5 mL). It is identified by NDC number 58160-976-02. The label also shows GlaxoSmithKline Biologicals SA as the manufacturer with space for lot and expiration date information. A barcode and product logo are visible as well.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.